Inogen (INGN): Raising PT to $66 - Needham
Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.
Needham & Company analyst, Mike Matson, reiterated his Strong Buy rating on shares of Inogen, Inc (NASDAQ: INGN) and raised his price target to $66 (from $64) after INGN beat consensus revenue, EBITDA, and EPS in 3Q16. Management also raised its 2016 revenue guidance and offered initial 2017 revenue, EBITDA, and EPS guidance that was above consensus.
The revenue upside was driven by 76% growth in the B2B business more than offsetting modest 1% growth in the DTC business. And despite a Y/Y gross margin decline driven mainly by mix and reimbursement cuts, INGN's operating improved Y/Y. We expect INGN's growth to continue to increase as the G4 becomes more widely available across its different sales channels.
Shares of Inogen, Inc closed at $50.25 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mizuho Securities Upgrades Lululemon Athletica Inc. (LULU) to Buy; Sees Upside Continuing
- Mizuho Securities Upgrades Tailored Brands (TLRD) to Buy
- FBR Capital Raises Price Target on Customers Bancorp (CUBI) to $40; Reiterates Outperform
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst PT Change, Earnings
Related EntitiesNeedham & Company
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!